Brazil Revises Procedures for Imports of COVID-19-Related Medicine, Vaccines
Brazil recently introduced new requirements surrounding imports of medicines to combat and vaccines to prevent COVID-19, the Hong Kong Trade Development Council reported May 5. Those imports must be “specifically indicated for the treatment or prevention” of COVID-19, must be…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
approved by a foreign health authority and must have “at least Phase 3 clinical studies completed or with provisional results,” HKTDC said. The country also simplified other procedures around importing “priority medical devices and medicines” that aren’t authorized in Brazil on a “temporary and exceptional basis.” Those products must be prequalified by the World Health Organization or meet other foreign regulatory standards, HKTDC said, and must prove compliance with “good manufacturing practices.”